The Bionics Institute of Australia
9
4
4
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
1 terminated/withdrawn out of 9 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
EarGenie MVP Performance Evaluation
Role: lead
The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis
Role: lead
Benefits of Choir for Older Adults With Unaddressed Hearing Loss (WP2)
Role: collaborator
Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)
Role: lead
The Development of a System for Measurement of Tremor
Role: lead
EarGenie: Assessment of a Minimum Viable Product
Role: lead
Longitudinal Study of a Bionic Eye
Role: collaborator
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
Role: collaborator
Study of a Suprachoroidal Retinal Prosthesis
Role: collaborator
All 9 trials loaded